| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |